enVVeno Medical Corporation Warrants
NVNOW
NVNOW was delisted on the 26th of May, 2023.
3 hedge funds and large institutions have $32K invested in enVVeno Medical Corporation Warrants in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
3,100% more capital invested
Capital invested by funds: $1K → $32K (+$31K)
0% more funds holding
Funds holding: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$11.1K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $28K | +$11.1K | +82,726 | +1,783% |
|
|
PAG
2
Private Advisor Group
Morristown,
New Jersey
| $3K | – | – | – |
|
|
NFSG
3
Newbridge Financial Services Group
Boca Raton,
Florida
| $1K | – | – | – |
|
NVNOW Hedge Fund Activity: Q4 2020 in Review
3 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical Corporation Warrants (NVNOW) for Q4 2020, worth a combined $32K — up 3,100% from $1K a quarter earlier.
Fund positioning in NVNOW was balanced in Q4 2020: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $11.1K.
- 3 institutional investors held enVVeno Medical Corporation Warrants (NVNOW) as of Q4 2020, unchanged from Q3 2020.
- Funds reported $32K of enVVeno Medical Corporation Warrants stock for Q4 2020, up 3,100% quarter-over-quarter.
- 0 funds opened new enVVeno Medical Corporation Warrants positions in Q4 2020 and 0 closed out.
- The largest enVVeno Medical Corporation Warrants buyer in Q4 2020 was UBS Group, an estimated $11.1K added.
Based on aggregated 13F filings for Q4 2020.